Affiliations 

  • 1 Faculty of Medical Sciences, The University of the West Indies, Cave Hill Campus, Bridgetown, Barbados
  • 2 Karnavati University, Ahmedabad, Gujarat, India
  • 3 Shri Ramkrishna Institute of Medical Science, Durgapur, West Bengal, India
  • 4 Sree Balaji Medical College and Hospital, Chennai, Tamil Nadu, India
  • 5 Department of Medical Surgical Nursing (Critical care nursing), Shri Anand Institute of Nursing, Rajkot, Gujarat, India
  • 6 Govt. Medical College, Shivpuri, Madhya Pradesh, India
  • 7 American University of Integrative Sciences (AUIS), Bridgetown, Barbados
  • 8 Anglia Ruskin University, Chelmsford, Essex, United Kingdom
  • 9 Department of Population Sciences, University of Dhaka, Dhaka, Bangladesh
  • 10 Health Education Department, Empower Me First College, Geneva, Switzerland
  • 11 Queen Elizabeth Hospital, Bridgetown, Barbados
  • 12 National Defence University of Malaysia, Kuala Lumpur, Malaysia
PeerJ, 2024;12:e17083.
PMID: 38590705 DOI: 10.7717/peerj.17083

Abstract

Studies focusing on the safety and common side effects of vaccines play a crucial role in enhancing public acceptance of vaccination. Research is scarce regarding the usage of COVID-19 vaccines and the side effects experienced by health professions students in India and other countries. This study aimed to document self-reported side effects associated with COVID-19 vaccination among medical and dental students of six medical and dental colleges and teaching hospitals in four states (Tamil Nadu, Madhya Pradesh, Gujarat, and West Bengal) of India. A cross-sectional survey using purposive sampling of medical and dental students was conducted from 26 April to 26 May 2021. Data was collected using a Google Forms questionnaire capturing information regarding receiving COVID-19 vaccines, side effects and symptoms, onset and duration of symptoms, use of treatment to alleviate symptoms, awareness of haematologic risks associated with vaccination, and side effects from previous (non-COVID-19) vaccinations. The majority (94.5%) of participants received both doses of the Covishield/AstraZeneca COVID-19 vaccine. Among participants (n = 492), 45.3% (n = 223) reported one or more side effects. The most frequently reported side effects were soreness of the injected arm (80.3%), tiredness (78.5%), fever (71.3%), headache (64.1%), and hypersomnia (58.7%). The two most common severe symptoms were fever (14.8%) and headache (13%). Most side effects appeared on the day of vaccination: soreness of the injection site (57%), fever (43.1%), and tiredness (42.6%). Most reported symptoms persisted for one to three days-soreness of the injection site (53%), fever (47.1%), and headache (42.6%). Logistic regression showed that women were almost 85% less likely to report side effects. The study's findings corroborate the safety of the Covishield/AstraZeneca vaccine's first dose, evidenced by the relatively minor and transient nature of the side effects. However, the study underscores the necessity for ongoing research to assess the long-term impacts of COVID-19 vaccines, especially in the context of booster doses, thereby contributing to the global understanding of vaccine safety and efficacy.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.